https://news.medxy.ai/zh/parkinsons-pain-perception/Medxy AIzh2026-11-12T02:46:09-08:00帕金森病疼痛感知：基于患者叙述改进照护的启示 https://news.medxy.ai/ja/parkinsons-pain-perception-perspectives/Medxy AIja2026-11-12T02:45:49-08:00パーキンソン病における疼痛の捉え方：患者の語りに基づくケア改善への示唆 https://news.medxy.ai/vi/parkinsons-pain-perspectives/Medxy AIvi2026-11-12T02:45:30-08:00Đau trong bệnh Parkinson được nhìn nhận như thế nào? Góc nhìn từ lời kể của người bệnh để cải thiện chăm sóc https://news.medxy.ai/pain-perception-in-parkinsons-disease-insights-from-patient-narratives-to-improve-care/Medxy AIen2026-11-12T02:45:14-08:00Pain Perception in Parkinson’s Disease: Insights from Patient Narratives to Improve Care https://news.medxy.ai/zh/aesthetic-crown-lengthening-trial/Medxy AIzh2026-11-12T02:44:33-08:00美学冠延长术中 piezosurgery 与旋转切骨钻的比较：一项裂口随机试验 https://news.medxy.ai/ja/piezosurgery-vs-rotary-burs/Medxy AIja2026-11-12T02:44:15-08:00審美的歯冠長延長術におけるPiezosurgeryとRotary Bursの比較：スプリットマウス無作為化試験 https://news.medxy.ai/vi/piezosurgery-vs-rotary-drill/Medxy AIvi2026-11-12T02:43:53-08:00Piezosurgery hay mũi khoan xoay: đâu là lựa chọn tốt hơn trong kéo dài thân răng thẩm mỹ? https://news.medxy.ai/comparing-piezosurgery-and-rotary-burs-in-aesthetic-crown-lengthening-a-split-mouth-randomised-trial/Medxy AIen2026-11-12T02:43:34-08:00Comparing Piezosurgery and Rotary Burs in Aesthetic Crown Lengthening: A Split-Mouth Randomised Trial https://news.medxy.ai/zh/ruzaltatug-egfr-lung-cancer/Medxy AIzh2026-11-12T02:42:55-08:00HER3 靶向药物 Ruzaltatug rezetecan 治疗 EGFR 突变晚期 NSCLC：HERON-Lung01 3 期中期分析优于化疗 https://news.medxy.ai/ja/ruzaltatug-rezetecan-vs-chemotherapy/Medxy AIja2026-11-12T02:42:35-08:00EGFR変異陽性進行NSCLCに対するRuzaltatug rezetecanと化学療法の比較：HERON-Lung01第3相中間解析 https://news.medxy.ai/vi/ruzaltatug-outperforms-chemotherapy/Medxy AIvi2026-11-12T02:42:09-08:00Ruzaltatug rezetecan vượt hóa trị ở NSCLC tiến triển có đột biến EGFR sau điều trị EGFR-TKI: Phân tích tạm thời pha 3 HERON-Lung01 https://news.medxy.ai/ruzaltatug-rezetecan-versus-chemotherapy-for-egfr-mutated-advanced-nsclc-post-egfr-tki-therapy-interim-phase-3-heron-lung01-analysis/Medxy AIen2026-11-12T02:41:50-08:00Ruzaltatug Rezetecan Versus Chemotherapy for EGFR-Mutated Advanced NSCLC Post-EGFR TKI Therapy: Interim Phase 3 HERON-Lung01 Analysis https://news.medxy.ai/ja/mild-pyuria-antibiotics-suspected-pediatric-uti/Medxy AIja2026-11-12T02:40:50-08:00小児のUTI疑いにおける軽度膿尿と抗菌薬処方 https://news.medxy.ai/vi/low-grade-pyuria-antibiotic-prescribing/Medxy AIvi2026-11-12T02:40:28-08:00Tiểu mủ mức độ thấp và việc kê đơn kháng sinh trong nghi ngờ nhiễm khuẩn đường tiết niệu ở trẻ em https://news.medxy.ai/low-level-pyuria-and-antibiotic-prescribing-for-suspected-urinary-tract-infection-in-children/Medxy AIen2026-11-12T02:40:11-08:00Low-Level Pyuria and Antibiotic Prescribing for Suspected Urinary Tract Infection in Children https://news.medxy.ai/zh/blinatumomab-vasculitis-study/Medxy AIzh2026-11-12T02:39:32-08:00Blinatumomab 治疗皮肌炎与难治性 ANCA 相关性血管炎的新探索：来自2例患者研究的启示 https://news.medxy.ai/ja/blinatumomab-treatment-study/Medxy AIja2026-11-12T02:39:15-08:00皮膚筋炎と難治性ANCA関連血管炎への新規治療としてのブリナツモマブ：2例研究から得られた知見 https://news.medxy.ai/vi/promising-treatment-for-dermatomyositis-and-anca-vasculitis/Medxy AIvi2026-11-12T02:38:57-08:00Blinatumomab: Hướng điều trị mới đầy hứa hẹn cho viêm da cơ và viêm mạch liên quan ANCA kháng trị từ nghiên cứu trên hai bệnh nhân https://news.medxy.ai/exploring-blinatumomab-as-a-novel-therapy-for-dermatomyositis-and-refractory-anca-associated-vasculitis-insights-from-a-two-patient-study/Medxy AIen2026-11-12T02:38:41-08:00Exploring Blinatumomab as a Novel Therapy for Dermatomyositis and Refractory ANCA-Associated Vasculitis: Insights from a Two-Patient Study https://news.medxy.ai/zh/living-donor-mental-health/Medxy AIzh2026-11-12T02:38:00-08:00提升活体捐献者心理健康结局：当前认识与未来方向 https://news.medxy.ai/ja/improving-donor-mental-health/Medxy AIja2026-11-12T02:37:36-08:00生体ドナーのメンタルヘルス転帰を高めるには：現状の知見と今後の展望 https://news.medxy.ai/vi/mental-health-outcomes/Medxy AIvi2026-11-12T02:37:03-08:00Nâng cao kết cục sức khỏe tâm thần ở người hiến sống: hiểu biết hiện nay và định hướng tương lai https://news.medxy.ai/enhancing-mental-health-outcomes-in-living-donors-current-insights-and-future-directions/Medxy AIen2026-11-12T02:36:45-08:00Enhancing Mental Health Outcomes in Living Donors: Current Insights and Future Directions https://news.medxy.ai/zh/ruxolitinib-atopic-dermatitis/Medxy AIzh2026-11-12T02:36:04-08:00Ruxolitinib cream治疗儿童特应性皮炎：来自3期TRuE-AD3试验的长期安全性与持续控制结果 https://news.medxy.ai/ja/ruxolitinib-long-term-safety/Medxy AIja2026-11-12T02:35:44-08:00小児アトピー性皮膚炎に対するルキソリチニブクリームの長期安全性と持続的コントロール：第3相TRuE-AD3試験からの知見 https://news.medxy.ai/vi/ruxolitinib-atopic-dermatitis-2/Medxy AIvi2026-11-12T02:35:21-08:00Kem ruxolitinib trong viêm da cơ địa ở trẻ em: bằng chứng về độ an toàn dài hạn và kiểm soát bệnh bền vững từ thử nghiệm pha 3 TRuE-AD3 https://news.medxy.ai/long-term-safety-and-sustained-control-of-atopic-dermatitis-in-children-treated-with-ruxolitinib-cream-insights-from-the-phase-3-true-ad3-trial/Medxy AIen2026-11-12T02:35:03-08:00Long-term Safety and Sustained Control of Atopic Dermatitis in Children Treated with Ruxolitinib Cream: Insights from the Phase 3 TRuE-AD3 Trial https://news.medxy.ai/zh/diep-flap-complications/Medxy AIzh2026-11-12T02:34:19-08:00DIEP皮瓣乳房重建如何减少供区并发症？腹直肌后可吸收聚乙交酯网片与个体化疝风险评估的新证据 https://news.medxy.ai/ja/diep-flap-complications-2/Medxy AIja2026-11-12T02:34:01-08:00DIEP flap乳房再建後のドナー部位合併症を減らすには：retrorectusポリグラクチンメッシュの有効性と個別化ヘルニアリスク推定 https://news.medxy.ai/vi/reducing-donor-site-complications/Medxy AIvi2026-11-12T02:33:08-08:00Giảm biến chứng tại vị trí cho vạt trong tái tạo vú bằng vạt DIEP: Hiệu quả của lưới polyglactin đặt retrorectus và ước tính nguy cơ thoát vị cá thể hóa https://news.medxy.ai/reducing-donor-site-complications-in-diep-flap-breast-reconstruction-the-efficacy-of-retrorectus-polyglactin-mesh-and-personalized-hernia-risk-estimation/Medxy AIen2026-11-12T02:32:49-08:00Reducing Donor-Site Complications in DIEP Flap Breast Reconstruction: The Efficacy of Retrorectus Polyglactin Mesh and Personalized Hernia Risk Estimation https://news.medxy.ai/zh/long-term-sepsis-mortality/Medxy AIzh2026-11-12T02:32:06-08:00脓毒症幸存者的长期死亡负担有多重？——来自加泰罗尼亚15年队列研究的启示 https://news.medxy.ai/ja/long-term-sepsis-mortality-3/Medxy AIja2026-11-12T02:31:45-08:00敗血症生存者における長期死亡負担を可視化：カタルーニャ15年間コホート研究からの知見 https://news.medxy.ai/vi/long-term-sepsis-mortality-2/Medxy AIvi2026-11-12T02:31:26-08:00Gánh nặng tử vong dài hạn ở người sống sót sau sepsis: phát hiện từ nghiên cứu đoàn hệ 15 năm tại Catalonia https://news.medxy.ai/unveiling-the-long-term-mortality-burden-among-sepsis-survivors-insights-from-a-15-year-catalonia-cohort-study/Medxy AIen2026-11-12T02:31:04-08:00Unveiling the Long-Term Mortality Burden Among Sepsis Survivors: Insights from a 15-Year Catalonia Cohort Study https://news.medxy.ai/ja/vr-pain-relief-feasibility/Medxy AIja2026-11-12T02:30:25-08:00鎌状赤血球症の疼痛緩和におけるVRの実現可能性と受容性：パイロット研究 https://news.medxy.ai/vi/virtual-reality-pain-relief/Medxy AIvi2026-11-12T02:30:09-08:00Thực tế ảo có khả thi trong giảm đau khi tắc nghẽn mạch ở bệnh hồng cầu hình liềm? Kết quả từ một nghiên cứu thí điểm https://news.medxy.ai/feasibility-and-acceptability-of-virtual-reality-for-pain-relief-during-vaso-occlusive-episodes-in-sickle-cell-disease-a-pilot-study/Medxy AIen2026-11-12T02:29:50-08:00Feasibility and Acceptability of Virtual Reality for Pain Relief During Vaso-occlusive Episodes in Sickle Cell Disease: A Pilot Study https://news.medxy.ai/zh/functional-platelet-rig-i/Medxy AIzh2026-11-12T02:29:11-08:00血小板中的功能性 RIG-I：流感感染期间血栓调控的新机制 https://news.medxy.ai/ja/functional-platelet-rig-i-2/Medxy AIja2026-11-12T02:28:51-08:00血小板における機能的RIG-I：インフルエンザ感染時の血栓形成を調節する新たな因子 https://news.medxy.ai/vi/rigi-platelet-function-thrombosis/Medxy AIvi2026-11-12T02:28:32-08:00RIG-I chức năng trong tiểu cầu: Bộ điều biến mới của huyết khối trong nhiễm cúm https://news.medxy.ai/functional-rig-i-in-platelets-a-novel-modulator-of-thrombosis-during-influenza-infection/Medxy AIen2026-11-12T02:28:14-08:00Functional RIG-I in Platelets: A Novel Modulator of Thrombosis During Influenza Infection https://news.medxy.ai/zh/predicting-copd-risk/Medxy AIzh2026-11-12T02:27:34-08:00预测 COPD 发生：跨多元队列验证实用 Pre-COPD 评分体系 https://news.medxy.ai/ja/predicting-copd-onset/Medxy AIja2026-11-12T02:27:16-08:00COPD発症を見据えた予測：実用的Pre-COPDスコアの多様コホートにおける検証 https://news.medxy.ai/vi/predicting-copd-onset-2/Medxy AIvi2026-11-12T02:26:57-08:00Dự báo khởi phát COPD: Thẩm định một thang điểm Pre-COPD thực tiễn trên nhiều đoàn hệ khác nhau https://news.medxy.ai/predicting-copd-onset-validation-of-a-practical-pre-copd-scoring-system-across-diverse-cohorts/Medxy AIen2026-11-12T02:26:40-08:00Predicting COPD Onset: Validation of a Practical Pre-COPD Scoring System Across Diverse Cohorts https://news.medxy.ai/zh/primary-congenital-glaucoma-treatment-comparison/Medxy AIzh2026-11-12T02:25:44-08:00原发性先天性青光眼中单纯小梁切开术与联合小梁切开术-小梁切除术的3年疗效比较 https://news.medxy.ai/ja/trabeculotomy-vs-combined-surgery-primary-congenital-glaucoma/Medxy AIja2026-11-12T02:25:28-08:00原発性先天緑内障における単純線維柱帯切開術と線維柱帯切開術・線維柱帯切除術併用術の3年間の治療成績の比較 https://news.medxy.ai/vi/trabeculotomy-vs-combined-surgery/Medxy AIvi2026-11-12T02:25:10-08:00Trabeculotomy đơn thuần so với phối hợp trabeculotomy-trabeculectomy ở glôcôm bẩm sinh nguyên phát có giãn giác mạc mức độ trung bình: Kết quả 3 năm https://news.medxy.ai/comparative-three-year-outcomes-of-trabeculotomy-versus-combined-trabeculotomy-trabeculectomy-in-primary-congenital-glaucoma-with-moderate-corneal-enlargement/Medxy AIen2026-11-12T02:24:54-08:00Comparative Three-Year Outcomes of Trabeculotomy Versus Combined Trabeculotomy-Trabeculectomy in Primary Congenital Glaucoma with Moderate Corneal Enlargement https://news.medxy.ai/zh/cholesteatoma-recurrence-risk-factors/Medxy AIzh2026-11-12T02:24:12-08:00胆脂瘤复发/残留：识别儿童高风险因素与疾病模式，优化管理策略 https://news.medxy.ai/ja/pediatric-cholesteatoma-recurrence/Medxy AIja2026-11-12T02:23:54-08:00小児で高い真珠腫再発リスク：病変進展と術式からみた最適管理の要点 https://news.medxy.ai/vi/pediatric-cholesteatoma-recurrence-2/Medxy AIvi2026-11-12T02:23:37-08:00Tái phát cholesteatoma ở trẻ em: nhận diện nguy cơ và mô hình bệnh để tối ưu hóa xử trí https://news.medxy.ai/cholesteatoma-recidivism-distinguishing-pediatric-risks-and-disease-patterns-for-optimized-management/Medxy AIen2026-11-12T02:23:20-08:00Cholesteatoma Recidivism: Distinguishing Pediatric Risks and Disease Patterns for Optimized Management https://news.medxy.ai/zh/neoadjuvant-pd1-melanoma/Medxy AIzh2026-11-12T02:22:38-08:00可切除Ⅲ期黑色素瘤中新辅助 PD-1 抑制剂疗效差异：淋巴结转移与移行转移的比较 https://news.medxy.ai/ja/pd1-neoadjuvant-melanoma/Medxy AIja2026-11-12T02:22:21-08:00切除可能なIII期メラノーマにおける術前PD-1阻害薬療法の有効性の差異：リンパ節転移と移行転移の比較 https://news.medxy.ai/vi/pd1-neoadjuvant-for-melanoma/Medxy AIvi2026-11-12T02:21:59-08:00Sự khác biệt về hiệu quả của các thuốc ức chế PD-1 trong điều trị tân bổ trợ đối với bệnh ung thư hắc tố giai đoạn III có thể phẫu thuật https://news.medxy.ai/distinct-clinical-outcomes-of-neoadjuvant-pd-1-inhibitors-in-resectable-stage-iii-melanoma-lymph-node-versus-in-transit-metastases/Medxy AIen2026-11-12T02:21:44-08:00Distinct Clinical Outcomes of Neoadjuvant PD-1 Inhibitors in Resectable Stage III Melanoma: Lymph Node Versus In-Transit Metastases https://news.medxy.ai/zh/baclofen-vaginal-suppositories/Medxy AIzh2026-11-12T02:21:05-08:00巴氯芬阴道栓剂治疗慢性盆腔痛：来自高质量随机对照试验的疗效证据及临床启示 https://news.medxy.ai/ja/baclofen-vaginal-suppositories-for-pelvic-pain/Medxy AIja2026-11-12T02:20:49-08:00慢性骨盤痛に対するバクロフェン膣坐剤：質の高いランダム化比較試験に基づく有効性のエビデンスと臨床的示唆 https://news.medxy.ai/vi/baclofen-vaginal-suppositories-pelvic-pain/Medxy AIvi2026-11-12T02:20:25-08:00Viên đặt âm đạo baclofen trong đau vùng chậu mạn tính: hiệu quả từ một thử nghiệm ngẫu nhiên có đối chứng quy mô lớn và ý nghĩa lâm sàng https://news.medxy.ai/vi/modern-hepatitis-d-care/Medxy AIvi2026-11-12T02:20:13-08:00AASLD EXPO: Hiện đại hóa tiếp cận viêm gan D — Ai cần xét nghiệm, ai cần điều trị và theo dõi như thế nào https://news.medxy.ai/baclofen-vaginal-suppositories-in-chronic-pelvic-pain-efficacy-from-a-robust-randomized-controlled-trial-and-clinical-implications/Medxy AIen2026-11-12T02:20:08-08:00Baclofen Vaginal Suppositories in Chronic Pelvic Pain: Efficacy from a Robust Randomized Controlled Trial and Clinical Implications https://news.medxy.ai/zh/hepatitis-delta-care/Medxy AIzh2026-11-12T02:19:47-08:00AASLD EXPO：重塑丁型肝炎诊疗路径——谁需要检测、谁应治疗、如何随访监测 https://news.medxy.ai/ja/hepatitis-delta-management/Medxy AIja2026-11-12T02:19:43-08:00AASLD EXPO：肝炎デルタへの最新アプローチ——誰を検査し、誰を治療し、どのようにモニタリングするか https://news.medxy.ai/hepatitis-d-management/Medxy AIen2026-11-12T02:19:23-08:00AASLD EXPO: Modernizing the Approach to Hepatitis D — Who to Test, Who to Treat, and How to Monitor https://news.medxy.ai/zh/late-nc-cognitive-decline/Medxy AIzh2026-11-12T02:18:24-08:00LATE-NC与认知下降：来自巴西多样化尸检队列的研究启示 https://news.medxy.ai/ja/late-nc-cognitive-decline-brazil-autopsy-cohort/Medxy AIja2026-11-12T02:18:05-08:00LATE-NCと認知機能低下：多様なブラジル剖検コホートから得られた知見 https://news.medxy.ai/vi/late-nc-cognitive-decline-brazil/Medxy AIvi2026-11-12T02:17:50-08:00LATE-NC và sự suy giảm nhận thức: Những hiểu biết từ một nhóm đối tượng đa dạng trong nghiên cứu khám nghiệm tử thi tại Brazil https://news.medxy.ai/late-nc-and-cognitive-decline-insights-from-a-diverse-brazilian-autopsy-cohort/Medxy AIen2026-11-12T02:17:34-08:00LATE-NC and Cognitive Decline: Insights from a Diverse Brazilian Autopsy Cohort https://news.medxy.ai/zh/slc2a2-glimepiride-efficacy/Medxy AIzh2026-11-12T02:16:54-08:00SLC2A2遗传变异如何影响格列美脲疗效：来自 GRADE 试验的血糖反应新发现 https://news.medxy.ai/ja/slc2a2-genetic-variants/Medxy AIja2026-11-12T02:16:38-08:00グリメピリドの血糖応答を左右するSLC2A2遺伝変異：GRADE試験から見えた薬効差の背景 https://news.medxy.ai/vi/slc2a2-glimepiride-response/Medxy AIvi2026-11-12T02:16:28-08:00Biến thể SLC2A2 và đáp ứng với glimepiride: gợi ý di truyền từ thử nghiệm GRADE https://news.medxy.ai/genetic-insights-into-glycemic-response-role-of-slc2a2-variants-in-sulfonylurea-efficacy-from-the-grade-trial/Medxy AIen2026-11-12T02:16:14-08:00Genetic Insights into Glycemic Response: Role of SLC2A2 Variants in Sulfonylurea Efficacy from the GRADE Trial https://news.medxy.ai/zh/transseptal-tmvr-outcomes/Medxy AIzh2026-11-12T02:15:36-08:00经皮经房间隔TMVR的持久疗效与安全性：ENCIRCLE试验2年结果 https://news.medxy.ai/ja/two-year-tmvr-results/Medxy AIja2026-11-12T02:15:15-08:00経皮的経中隔TMVRの持続的有効性と安全性：ENCIRCLE試験2年成績 https://news.medxy.ai/vi/transcatheter-tmvr-outcomes/Medxy AIvi2026-11-12T02:14:56-08:00TMVR xuyên vách liên nhĩ bằng đường qua da: Hiệu quả và an toàn bền vững sau 2 năm từ thử nghiệm ENCIRCLE https://news.medxy.ai/durable-efficacy-and-safety-of-percutaneous-transseptal-tmvr-two-year-outcomes-from-the-encircle-trial/Medxy AIen2026-11-12T02:14:38-08:00Durable Efficacy and Safety of Percutaneous Transseptal TMVR: Two-Year Outcomes from the ENCIRCLE Trial https://news.medxy.ai/zh/oncology-trainee-diversity-trends/Medxy AIzh2026-11-12T02:13:54-08:00肿瘤学多元化进展：2011—2025年培训人员种族与族裔代表性趋势 https://news.medxy.ai/ja/diversity-in-oncology-training/Medxy AIja2026-11-12T02:13:33-08:00腫瘍学における多様性の前進：2011年から2025年にかけての研修中医師における人種・民族構成の動向 https://news.medxy.ai/vi/racial-diversity-oncology/Medxy AIvi2026-11-12T02:13:14-08:00Tăng cường đa dạng trong ung bướu: xu hướng đại diện chủng tộc và sắc tộc ở học viên giai đoạn 2011–2025 https://news.medxy.ai/advancing-diversity-in-oncology-trends-in-racial-and-ethnic-representation-among-trainees-from-2011-to-2025/Medxy AIen2026-11-12T02:13:00-08:00Advancing Diversity in Oncology: Trends in Racial and Ethnic Representation Among Trainees from 2011 to 2025 https://news.medxy.ai/zh/adipose-stromal-therapy-knee-osteoarthritis/Medxy AIzh2026-11-12T02:12:23-08:00单次自体基质血管组分注射治疗中重度膝骨关节炎的疗效：来自多中心随机对照试验的启示 https://news.medxy.ai/ja/adipose-stromal-therapy-for-knee-osteoarthritis/Medxy AIja2026-11-12T02:12:08-08:00中等度から重度の膝変形性関節症に対する自己由来基質血管画分（SVF）の単回注射療法の有効性：多施設共同ランダム化比較試験からの知見 https://news.medxy.ai/vi/adipose-stromal-cell-therapy-knee-osteoarthritis/Medxy AIvi2026-11-12T02:11:47-08:00Hiệu quả của một lần tiêm phân đoạn mạch máu mô đệm tự thân (autologous stromal vascular fraction) trong điều trị thoái hóa khớp gối mức độ trung bình đến nặng https://news.medxy.ai/efficacy-of-a-single-autologous-stromal-vascular-fraction-injection-for-moderate-to-severe-knee-osteoarthritis-insights-from-a-multicenter-randomized-controlled-trial/Medxy AIen2026-11-12T02:11:31-08:00Efficacy of a Single Autologous Stromal Vascular Fraction Injection for Moderate-to-Severe Knee Osteoarthritis: Insights from a Multicenter Randomized Controlled Trial https://news.medxy.ai/zh/pace-impact-young-disabled-adults/Medxy AIzh2026-11-12T02:10:48-08:00PACE对较年轻残障成年人影响如何？——健康、参与度与医疗利用结局分析 https://news.medxy.ai/ja/pace-impact-on-young-disabled-adults/Medxy AIja2026-11-12T02:10:33-08:00PACEは若年層の障害を持つ成人にどのような影響を及ぼすか？――健康、社会参加、および医療利用に関するアウトカム分析 https://news.medxy.ai/vi/pace-impact-young-adults-disabilities/Medxy AIvi2026-11-12T02:10:16-08:00Đánh giá tác động của PACE ở người trưởng thành trẻ sống chung với khuyết tật: kết cục về sức khỏe, sự gắn kết và sử dụng dịch vụ y tế https://news.medxy.ai/evaluating-the-impact-of-pace-on-younger-adults-with-disabilities-health-engagement-and-healthcare-utilization-outcomes/Medxy AIen2026-11-12T02:10:00-08:00Evaluating the Impact of PACE on Younger Adults with Disabilities: Health, Engagement, and Healthcare Utilization Outcomes https://news.medxy.ai/zh/silver-fluoride-vs-restorations/Medxy AIzh2026-11-12T02:09:22-08:00老年人龋病管理：银氨氟化物与无创修复治疗孰优？——来自整群随机试验的启示 https://news.medxy.ai/ja/silver-diamine-fluoride-restorative-care/Medxy AIja2026-11-12T02:09:04-08:00高齢者のう蝕管理における銀ジアミンフッ化物と非侵襲的修復治療：クラスターランダム化試験からの知見 https://news.medxy.ai/vi/silver-diamine-fluoride-vs-atraumatic-restorative-treatment/Medxy AIvi2026-11-12T02:08:41-08:00Fluor bạc diamin so với điều trị phục hồi không gây sang chấn trong kiểm soát sâu răng ở người cao tuổi: góc nhìn từ một thử nghiệm ngẫu nhiên theo cụm https://news.medxy.ai/silver-diamine-fluoride-vs-atraumatic-restorations-for-caries-management-in-older-adults-insights-from-a-cluster-randomized-trial/Medxy AIen2026-11-12T02:08:26-08:00Silver Diamine Fluoride vs Atraumatic Restorations for Caries Management in Older Adults: Insights from a Cluster-Randomized Trial https://news.medxy.ai/zh/retatrutide-obesity-treatment/Medxy AIzh2026-11-12T02:07:50-08:00Retatrutide：用于肥胖及相关合并症管理的有前景三重激素受体激动剂 https://news.medxy.ai/ja/retatrutide-treatment-obesity/Medxy AIja2026-11-12T02:07:33-08:00レタトルチド：肥満および関連する合併症の管理に向けた、有望なトリプルホルモン受容体作動薬 https://news.medxy.ai/vi/retatrutide-obesity-treatment-2/Medxy AIvi2026-11-12T02:07:16-08:00Retatrutide: Chất chủ vận ba hormon đầy hứa hẹn trong điều trị béo phì và các bệnh đồng mắc liên quan https://news.medxy.ai/retatrutide-a-promising-triple-hormone-receptor-agonist-for-obesity-management-and-related-comorbidities/Medxy AIen2026-11-12T02:06:56-08:00Retatrutide: A Promising Triple Hormone Receptor Agonist for Obesity Management and Related Comorbidities https://news.medxy.ai/zh/virtual-reality-aphasia-therapy/Medxy AIzh2026-11-11T06:59:28-08:00沉浸式虚拟现实可增强慢性卒中后失语症的命名治疗效果：一项随机对照试验 https://news.medxy.ai/ja/immersive-vr-aphasia-training/Medxy AIja2026-11-11T06:59:10-08:00慢性期脳卒中後失語における呼称訓練を高める没入型VR：無作為化比較試験 https://news.medxy.ai/vi/immersive-vr-naming-therapy/Medxy AIvi2026-11-11T06:58:49-08:00Thực tế ảo nhập vai hỗ trợ trị liệu gọi tên ở mất ngôn ngữ mạn tính sau đột quỵ: một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/immersive-virtual-reality-enhances-naming-therapy-in-chronic-post-stroke-aphasia-a-randomized-controlled-trial/Medxy AIen2026-11-11T06:58:30-08:00Immersive Virtual Reality Enhances Naming Therapy in Chronic Post-Stroke Aphasia: A Randomized Controlled Trial https://news.medxy.ai/zh/metagenomics-periodontal-disease/Medxy AIzh2026-11-11T06:57:44-08:00唾液微生物组在牙周病进展中的宏基因组学启示 https://news.medxy.ai/ja/salivary-microbiome-analysis/Medxy AIja2026-11-11T06:57:23-08:00歯周疾患の進行に伴う唾液マイクロバイオーム変化を読み解くメタゲノム解析 https://news.medxy.ai/vi/salivary-microbiome-periodontitis/Medxy AIvi2026-11-11T06:56:59-08:00Biến đổi hệ vi sinh vật nước bọt trong tiến triển bệnh nha chu: góc nhìn metagenome https://news.medxy.ai/metagenomic-insights-into-salivary-microbiome-shifts-during-periodontal-disease-progression/Medxy AIen2026-11-11T06:56:39-08:00Metagenomic Insights into Salivary Microbiome Shifts During Periodontal Disease Progression https://news.medxy.ai/zh/responsive-management-vs-dialysis-in-elder/Medxy AIzh2026-11-11T06:55:55-08:00英国高龄肾衰竭及衰弱患者的响应式管理与肾透析的比较有效性：“肾脏护理准备”（Prepare for Kidney Care）试验 https://news.medxy.ai/ja/responsive-management-vs-dialysis/Medxy AIja2026-11-11T06:55:29-08:00高齢の英国腎不全・フレイル患者におけるレスポンシブマネジメントと腎透析の比較有効性：Prepare for Kidney Care試験と関連研究からの知見 https://news.medxy.ai/vi/responsive-management-vs-dialysis-in-ckd-elder/Medxy AIvi2026-11-11T06:54:57-08:00So sánh hiệu quả giữa quản lý linh hoạt (responsive management) và lọc thận ở bệnh nhân cao tuổi tại Anh mắc suy thận và hội chứng suy yếu (frailty): Những phát hiện từ thử nghiệm “Prepare for Kidney Care” và các nghiên cứu liên quan https://news.medxy.ai/comparative-effectiveness-of-responsive-management-versus-renal-dialysis-in-elderly-uk-patients-with-kidney-failure-and-frailty/Medxy AIen2026-11-11T06:54:30-08:00Comparative Effectiveness of Responsive Management Versus Renal Dialysis in Elderly UK Patients with Kidney Failure and Frailty: Insights from the Prepare for Kidney Care Trial and Related Advances https://news.medxy.ai/ja/donor-milk-islamic-law/Medxy AIja2026-11-11T06:53:12-08:00米国のイスラム法ファトワが示したドナー母乳の活用：臨床家はいかに信仰指針を用いて新生児医療の公平性を高められるか https://news.medxy.ai/vi/islamic-fatwa-donor-milk/Medxy AIvi2026-11-11T06:52:42-08:00Fatwa Hồi giáo tại Hoa Kỳ ủng hộ sữa mẹ hiến tặng đã được thanh trùng: Bác sĩ có thể vận dụng hướng dẫn tôn giáo để cải thiện công bằng trong chăm sóc sơ sinh https://news.medxy.ai/zh/islamic-fatwa-donor-milk-2/Medxy AIzh2026-11-11T06:52:13-08:00美国伊斯兰法特瓦支持使用经过巴氏杀菌的供体母乳：临床人员如何借助宗教指导促进新生儿公平 https://news.medxy.ai/a-u-s-islamic-fatwa-supporting-pasteurized-donor-human-milk-how-clinicians-can-use-faith-guidance-to-improve-neonatal-equity/Medxy AIen2026-11-11T06:51:50-08:00A U.S. Islamic Fatwa Supporting Pasteurized Donor Human Milk: How Clinicians Can Use Faith Guidance to Improve Neonatal Equity https://news.medxy.ai/zh/musculoskeletal-burden-rising/Medxy AIzh2026-11-11T06:50:44-08:00劳动年龄人群肌肉骨骼疾病全球负担与经济影响持续攀升（1990—2023） https://news.medxy.ai/ja/musculoskeletal-disorders-burden-2/Medxy AIja2026-11-11T06:50:24-08:00労働年齢成人における筋骨格系疾患の世界的影響と経済的負担の増大（1990～2023年） https://news.medxy.ai/vi/global-musculoskeletal-disorders-epidemiology/Medxy AIvi2026-11-11T06:50:02-08:00Gánh nặng toàn cầu và chi phí kinh tế của rối loạn cơ xương khớp ở người trong độ tuổi lao động (1990–2023) https://news.medxy.ai/musculoskeletal-disorders-burden/Medxy AIen2026-11-11T06:49:44-08:00Rising Global Impact and Economic Burden of Musculoskeletal Disorders Among Working-Age Adults (1990–2023) https://news.medxy.ai/zh/chagas-positive-organ-transplantation/Medxy AIzh2026-11-11T06:48:59-08:00克氏锥虫阳性供体器官移植：肝肾移植受者的风险与获益如何平衡 https://news.medxy.ai/ja/trypanosoma-cruzi-transplant-risks-benefits/Medxy AIja2026-11-11T06:48:43-08:00<i>Trypanosoma cruzi</i>陽性ドナー臓器移植の実際――肝・腎移植におけるリスクと利益の均衡 https://news.medxy.ai/vi/trypanosoma-cruzi-transplant-risk-benefit/Medxy AIvi2026-11-11T06:48:25-08:00Ghép tạng từ người hiến dương tính với Trypanosoma cruzi: Cân bằng giữa nguy cơ và lợi ích cho người nhận ghép gan, ghép thận https://news.medxy.ai/transplanting-organs-from-trypanosoma-cruzi-positive-donors-balancing-risks-and-benefits-for-liver-and-kidney-recipients/Medxy AIen2026-11-11T06:48:09-08:00Transplanting Organs from Trypanosoma cruzi-Positive Donors: Balancing Risks and Benefits for Liver and Kidney Recipients https://news.medxy.ai/zh/cemiplimab-skin-cancer/Medxy AIzh2026-11-11T06:47:15-08:00低剂量病灶内注射 Cemiplimab 在早期皮肤鳞状细胞癌中显示出良好疗效：来自 1 期剂量递增研究的启示 https://news.medxy.ai/ja/low-dose-intralesional-cemiplimab-early-cutaneous-squamous-cell-carcinoma/Medxy AIja2026-11-11T06:46:51-08:00早期皮膚扁平上皮癌における低用量病変内セミプリマブの有望性：第1相用量漸増試験からの知見 https://news.medxy.ai/vi/low-dose-intralesional-cemiplimab-early-skin-cancer/Medxy AIvi2026-11-11T06:46:31-08:00Cemiplimab tiêm trong tổn thương liều thấp cho thấy hiệu quả đầy hứa hẹn ở ung thư biểu mô tế bào vảy da giai đoạn sớm: Góc nhìn từ nghiên cứu tăng liều pha 1 https://news.medxy.ai/low-dose-intralesional-cemiplimab-shows-promising-efficacy-in-early-stage-cutaneous-squamous-cell-carcinoma-insights-from-a-phase-1-dose-escalation-study/Medxy AIen2026-11-11T06:46:15-08:00Low-Dose Intralesional Cemiplimab Shows Promising Efficacy in Early-Stage Cutaneous Squamous Cell Carcinoma: Insights from a Phase 1 Dose-Escalation Study https://news.medxy.ai/zh/breast-reconstruction-after-radiation-2/Medxy AIzh2026-11-11T06:45:31-08:00乳房切除术后放疗后自体乳房重建：何时更安全？结局分析 https://news.medxy.ai/ja/timing-breast-reconstruction/Medxy AIja2026-11-11T06:45:09-08:00放射線治療後の自家組織乳房再建はいつが安全か：術後時期別の転帰を検証 https://news.medxy.ai/vi/autologous-breast-reconstruction-timing/Medxy AIvi2026-11-11T06:44:47-08:00Tái tạo vú tự thân sau xạ trị: thời điểm nào là an toàn và hiệu quả? https://news.medxy.ai/timing-of-autologous-breast-reconstruction-post-radiotherapy-evaluating-safety-and-outcomes/Medxy AIen2026-11-11T06:44:29-08:00Timing of Autologous Breast Reconstruction Post-Radiotherapy: Evaluating Safety and Outcomes https://news.medxy.ai/zh/integrated-hiv-services-injection-drug-users/Medxy AIzh2026-11-11T06:43:43-08:00面向注射吸毒者的 HIV 预防与成瘾治疗整合移动服务：HPTN 094 随机临床试验解读 https://news.medxy.ai/ja/hiv-prevention-addiction-treatment-mobile-unit/Medxy AIja2026-11-11T06:43:19-08:00注射薬物使用者に対するHIV予防と依存症治療の統合モバイルユニット：HPTN 094ランダム化臨床試験から得られた知見 https://news.medxy.ai/vi/mobile-hiv-prevention-injection-drug-use/Medxy AIvi2026-11-11T06:42:54-08:00Đơn vị di động tích hợp phòng ngừa nghiện và HIV cho người tiêm chích ma túy: Phát hiện từ thử nghiệm lâm sàng ngẫu nhiên HPTN 094 https://news.medxy.ai/mobile-units-for-integrated-addiction-and-hiv-prevention-services-for-people-who-inject-drugs-insights-from-the-hptn-094-randomized-clinical-trial/Medxy AIen2026-11-11T06:42:34-08:00Mobile Units for Integrated Addiction and HIV Prevention Services for People Who Inject Drugs: Insights from the HPTN 094 Randomized Clinical Trial https://news.medxy.ai/zh/high-flow-oxygen-stratification/Medxy AIzh2026-11-11T06:41:40-08:00免疫功能低下急性呼吸衰竭患者高流量鼻导管吸氧如何精准分层：机器学习带来的新启示 https://news.medxy.ai/ja/personalized-high-flow-oxygen/Medxy AIja2026-11-11T06:41:20-08:00免疫不全患者の急性呼吸不全における高流量経鼻酸素療法の個別化：機械学習が示す知見 https://news.medxy.ai/vi/personalized-high-flow-oxygen-therapy/Medxy AIvi2026-11-11T06:40:59-08:00Cá thể hóa liệu pháp ôxy qua mũi lưu lượng cao ở bệnh nhân suy giảm miễn dịch bị suy hô hấp cấp: góc nhìn từ học máy https://news.medxy.ai/tailoring-high-flow-nasal-oxygen-therapy-in-immunocompromised-patients-with-acute-respiratory-failure-insights-from-machine-learning/Medxy AIen2026-11-11T06:40:38-08:00Tailoring High Flow Nasal Oxygen Therapy in Immunocompromised Patients with Acute Respiratory Failure: Insights from Machine Learning https://news.medxy.ai/zh/patient-centered-kidney-care/Medxy AIzh2026-11-11T06:39:49-08:00提升终末期肾病以患者为中心的护理：ESKD生命计划工具包的开发与评估 https://news.medxy.ai/ja/patient-centered-kidney-care-2/Medxy AIja2026-11-11T06:39:31-08:00末期腎臓病における患者中心ケアを高める――ESKD Life Plan Toolkit の開発と評価 https://news.medxy.ai/vi/patient-centered-end-stage-kidney-care/Medxy AIvi2026-11-11T06:39:08-08:00Nâng cao chăm sóc lấy người bệnh làm trung tâm ở bệnh thận giai đoạn cuối: Phát triển và đánh giá Bộ công cụ Kế hoạch sống cho ESKD https://news.medxy.ai/enhancing-patient-centered-care-in-end-stage-kidney-disease-development-and-evaluation-of-the-eskd-life-plan-toolkit/Medxy AIen2026-11-11T06:38:51-08:00Enhancing Patient-Centered Care in End-Stage Kidney Disease: Development and Evaluation of the ESKD Life Plan Toolkit https://news.medxy.ai/zh/usp22-kmt2a-leukemia-therapy/Medxy AIzh2026-11-11T06:38:02-08:00USP22：KMT2A重排急性白血病的新治疗脆弱点——调控MEIS1稳定性与致癌转录 https://news.medxy.ai/ja/usp22-kmt2a-leukemia/Medxy AIja2026-11-11T06:37:44-08:00KMT2A再構成急性白血病における治療標的としてのUSP22：MEIS1安定性とがん原性転写の制御 https://news.medxy.ai/vi/usp22-kmt2a-leukemia-target/Medxy AIvi2026-11-11T06:37:22-08:00USP22: Mục tiêu điều trị đầy hứa hẹn trong bệnh bạch cầu cấp tái sắp xếp KMT2A, thông qua kiểm soát độ ổn định MEIS1 và phiên mã sinh ung thư https://news.medxy.ai/usp22-as-a-therapeutic-vulnerability-in-kmt2a-rearranged-acute-leukemia-regulating-meis1-stability-and-oncogenic-transcription/Medxy AIen2026-11-11T06:37:03-08:00USP22 as a Therapeutic Vulnerability in KMT2A-Rearranged Acute Leukemia: Regulating MEIS1 Stability and Oncogenic Transcription https://news.medxy.ai/zh/sleep-apnea-racial-disparities/Medxy AIzh2026-11-11T06:36:06-08:00关注黑人群体睡眠呼吸暂停漏检：氧去饱和与心率反应中的种族差异有何影响 https://news.medxy.ai/ja/preventing-sleep-apnea-misdiagnosis/Medxy AIja2026-11-11T06:35:48-08:00Black人における睡眠時無呼吸の見逃しをどう防ぐか：酸素飽和度低下と心拍数反応にみる人種差の意味 https://news.medxy.ai/vi/missed-sleep-apnea-black-patients/Medxy AIvi2026-11-11T06:35:25-08:00Bỏ sót ngưng thở khi ngủ ở người Da đen: vai trò của khác biệt chủng tộc trong giảm bão hòa oxy và đáp ứng nhịp tim https://news.medxy.ai/addressing-under-detection-of-sleep-apnea-in-black-individuals-the-role-of-racial-differences-in-oxygen-desaturation-and-heart-rate-response/Medxy AIen2026-11-11T06:35:10-08:00Addressing Under-Detection of Sleep Apnea in Black Individuals: The Role of Racial Differences in Oxygen Desaturation and Heart-Rate Response https://news.medxy.ai/zh/intravenous-bisphosphonates-to-uveitis-risk/Medxy AIzh2026-11-11T06:34:28-08:00静脉注射双膦酸盐与葡萄膜炎短期风险增加相关 https://news.medxy.ai/ja/intravenous-bisphosphonates-increase-uveitis-risk/Medxy AIja2026-11-11T06:34:10-08:00静脈内投与ビスホスホネート製剤は短期間のぶどう膜炎リスク上昇に関連する https://news.medxy.ai/vi/intravenous-bisphosphonates-uveitis-risk/Medxy AIvi2026-11-11T06:33:50-08:00Bisphosphonate tiêm tĩnh mạch liên quan đến nguy cơ viêm màng bồ đào ngắn hạn tăng: phát hiện từ nghiên cứu toàn quốc tại Đài Loan https://news.medxy.ai/intravenous-bisphosphonates-linked-to-increased-short-term-uveitis-risk-insights-from-a-nationwide-taiwan-study/Medxy AIen2026-11-11T06:33:29-08:00Intravenous Bisphosphonates Linked to Increased Short-Term Uveitis Risk: Insights from a Nationwide Taiwan Study https://news.medxy.ai/zh/limitations-of-preoperative-ultrasound/Medxy AIzh2026-11-11T06:32:39-08:00术前超声预测乳头状甲状腺癌特征的局限：对手术规划的临床启示 https://news.medxy.ai/ja/preoperative-ultrasound-limits-thyroid-cancer/Medxy AIja2026-11-11T06:32:11-08:00甲状腺乳頭癌における術前超音波の限界：手術計画に与える臨床的示唆 https://news.medxy.ai/vi/preoperative-ultrasound-limits/Medxy AIvi2026-11-11T06:31:44-08:00Giới hạn của siêu âm trước mổ trong dự đoán đặc điểm ung thư biểu mô nhú tuyến giáp: hàm ý lâm sàng cho lập kế hoạch phẫu thuật https://news.medxy.ai/limitations-of-preoperative-ultrasound-in-predicting-papillary-thyroid-carcinoma-features-clinical-implications-for-surgical-planning/Medxy AIen2026-11-11T06:31:27-08:00Limitations of Preoperative Ultrasound in Predicting Papillary Thyroid Carcinoma Features: Clinical Implications for Surgical Planning https://news.medxy.ai/zh/vegfa-egf-variants-cholangiocarcinoma/Medxy AIzh2026-11-11T06:30:42-08:00VEGFA 与 EGF 遗传变异：对胆管癌易感性及术后预后的影响 https://news.medxy.ai/ja/vegfa-egf-gene-variants-bile-duct-cancer/Medxy AIja2026-11-11T06:30:23-08:00VEGFA・EGF遺伝子多型が胆管癌に与える影響――感受性と術後予後をめぐる新知見 https://news.medxy.ai/vi/vegfa-egf-cholangiocarcinoma-risk/Medxy AIvi2026-11-11T06:30:00-08:00Đa hình di truyền của VEGFA và EGF: Ảnh hưởng đến nguy cơ mắc ung thư đường mật và tiên lượng sau phẫu thuật https://news.medxy.ai/vegfa-and-egf-genetic-variants-impact-on-cholangiocarcinoma-susceptibility-and-postoperative-prognosis/Medxy AIen2026-11-11T06:29:41-08:00VEGFA and EGF Genetic Variants: Impact on Cholangiocarcinoma Susceptibility and Postoperative Prognosis https://news.medxy.ai/zh/standard-vs-low-pressure-pneumoperitoneum/Medxy AIzh2026-11-11T06:28:57-08:00妇科腹腔镜手术中标准与低压气腹的差异 https://news.medxy.ai/ja/optimizing-insufflation-pressure-laparoscopy/Medxy AIja2026-11-11T06:28:30-08:00婦人科腹腔鏡手術における送気圧の最適化：ランダム化試験から得られた示唆 https://news.medxy.ai/vi/insufflation-pressure-laparoscopy/Medxy AIvi2026-11-11T06:28:02-08:00Tối ưu hóa áp lực bơm hơi trong phẫu thuật nội soi phụ khoa: Những gợi ý từ các thử nghiệm ngẫu nhiên https://news.medxy.ai/insights-from-a-randomized-trial-comparing-standard-and-lower-pressure-pneumoperitoneum-in-laparoscopic-gynecologic-surgery/Medxy AIen2026-11-11T06:27:39-08:00Insights from a Randomized Trial: Comparing Standard and Lower Pressure Pneumoperitoneum in Laparoscopic Gynecologic Surgery https://news.medxy.ai/zh/statins-aging-liver-health/Medxy AIzh2026-11-11T06:26:50-08:00他汀、衰老与肝脏健康：解析 MASLD 中年龄和性别对转录组应答的影响 https://news.medxy.ai/ja/statins-liver-aging-masld/Medxy AIja2026-11-11T06:26:29-08:00スタチンは肝老化にどう作用するのか：MASLDにおける年齢・性差とトランスクリプトーム応答 https://news.medxy.ai/vi/statins-aging-liver-health-2/Medxy AIvi2026-11-11T06:26:04-08:00Statin, lão hóa và sức khỏe gan: Giải mã ảnh hưởng của tuổi và giới tính lên đáp ứng transcriptome trong MASLD https://news.medxy.ai/statins-aging-and-liver-health-unraveling-age-and-sex-influence-on-transcriptomic-responses-in-masld/Medxy AIen2026-11-11T06:25:47-08:00Statins, Aging, and Liver Health: Unraveling Age and Sex Influence on Transcriptomic Responses in MASLD https://news.medxy.ai/zh/reproductive-hormones-for-neurovascular-health/Medxy AIzh2026-11-11T06:25:02-08:00生殖期与激素疗法如何影响高龄女性的神经血管健康? https://news.medxy.ai/ja/reproductive-hormones-neurovascular-health/Medxy AIja2026-11-11T06:24:40-08:00生殖期間とホルモン療法は高齢女性の神経血管の健康にどう関わるのか：エビデンスに基づくレビュー https://news.medxy.ai/vi/reproductive-timing-hormone-therapy/Medxy AIvi2026-11-11T06:24:12-08:00Thời gian sinh sản và liệu pháp hormon: ảnh hưởng đến sức khỏe mạch máu thần kinh về sau ở phụ nữ lớn tuổi sống trong cộng đồng — Tổng quan dựa trên bằng chứng https://news.medxy.ai/reproductive-lifespan-and-hormonal-therapy-in-relation-to-later-life-neurovascular-health-in-community-dwelling-older-women-an-evidence-based-review/Medxy AIen2026-11-11T06:23:48-08:00Reproductive Lifespan and Hormonal Therapy in Relation to Later-Life Neurovascular Health in Community-Dwelling Older Women: An Evidence-Based Review https://news.medxy.ai/zh/gestational-diabetes-maternal-morbidity/Medxy AIzh2026-11-11T06:22:48-08:00美国分娩住院中妊娠期糖尿病上升及其与严重孕产妇发病的关联（2016—2022年） https://news.medxy.ai/ja/gestational-diabetes-maternal-complications/Medxy AIja2026-11-11T06:22:26-08:00米国分娩入院における妊娠中の糖尿病増加と重篤な妊産婦合併症の推移（2016～2022年） https://news.medxy.ai/vi/gestational-diabetes-trends/Medxy AIvi2026-11-11T06:22:06-08:00Xu hướng đái tháo đường trong thai kỳ tăng cao và bệnh suất mẹ nặng liên quan trong các ca sinh nở tại Hoa Kỳ (2016-2022) https://news.medxy.ai/increasing-trends-in-diabetes-during-pregnancy-and-associated-severe-maternal-morbidity-in-u-s-deliveries-2016-2022/Medxy AIen2026-11-11T06:21:48-08:00Increasing Trends in Diabetes During Pregnancy and Associated Severe Maternal Morbidity in U.S. Deliveries (2016-2022) https://news.medxy.ai/zh/simplified-transfemoral-tavr-closure/Medxy AIzh2026-11-11T06:21:04-08:00经股动脉TAVR入路闭合更简化：SINGLE-CLOSURE试验带来的启示 https://news.medxy.ai/ja/simplified-transfemoral-access-site-closure-after-tavr/Medxy AIja2026-11-11T06:20:43-08:00経大腿動脈TAVRにおけるアクセス部位閉鎖の簡略化：SINGLE-CLOSURE試験が示唆するもの https://news.medxy.ai/vi/simplified-transfemoral-tavr-closure-2/Medxy AIvi2026-11-11T06:20:23-08:00Đơn giản hóa đóng vị trí vào trong TAVR qua đường đùi: Những phát hiện từ thử nghiệm SINGLE-CLOSURE https://news.medxy.ai/simplifying-access-site-closure-in-transfemoral-tavr-insights-from-the-single-closure-trial/Medxy AIen2026-11-11T06:20:05-08:00Simplifying Access Site Closure in Transfemoral TAVR: Insights from the SINGLE-CLOSURE Trial https://news.medxy.ai/zh/gluteal-nerve-palsy/Medxy AIzh2026-11-11T06:19:19-08:00髋关节镜术后臀神经麻痹：发生率、牵引影响及临床结局 https://news.medxy.ai/ja/pudendal-nerve-palsy/Medxy AIja2026-11-11T06:18:58-08:00股関節鏡視下手術後の陰部神経麻痺：発生頻度、牽引の影響、臨床転帰 https://news.medxy.ai/vi/pudendal-nerve-palsy-hip-arthroscopy/Medxy AIvi2026-11-11T06:18:32-08:00Liệt thần kinh thẹn sau nội soi khớp háng: Tỷ lệ mắc, ảnh hưởng của lực kéo và kết cục lâm sàng https://news.medxy.ai/postoperative-pudendal-nerve-palsy-after-hip-arthroscopy-incidence-traction-influence-and-clinical-outcomes/Medxy AIen2026-11-11T06:18:13-08:00Postoperative Pudendal Nerve Palsy After Hip Arthroscopy: Incidence, Traction Influence, and Clinical Outcomes https://news.medxy.ai/zh/obesity-inspiratory-muscle-training/Medxy AIzh2026-11-11T06:17:23-08:00肥胖管理新策略：功能性吸气肌训练的作用与价值 https://news.medxy.ai/ja/obesity-breathing-training/Medxy AIja2026-11-11T06:17:03-08:00肥満の機能改善をめざす新戦略：機能的吸気筋トレーニングの可能性 https://news.medxy.ai/vi/functional-inspiratory-muscle-training/Medxy AIvi2026-11-11T06:16:38-08:00Tăng cường năng lực chức năng ở người béo phì: Vai trò của huấn luyện cơ hít vào chức năng https://news.medxy.ai/enhancing-functional-capacity-in-obesity-the-role-of-functional-inspiratory-muscle-training/Medxy AIen2026-11-11T06:16:18-08:00Enhancing Functional Capacity in Obesity: The Role of Functional Inspiratory Muscle Training https://news.medxy.ai/zh/caries-risk-assessment/Medxy AIzh2026-11-11T06:15:28-08:00提升致龋风险评估：口腔 pH 动态的定量新框架 https://news.medxy.ai/ja/quantifying-oral-ph-dynamics/Medxy AIja2026-11-11T06:15:04-08:00口腔pH動態を数値化してう蝕リスク評価を高める：新たな解析枠組み https://news.medxy.ai/vi/caries-risk-assessment-2/Medxy AIvi2026-11-11T06:14:42-08:00Nâng cao đánh giá nguy cơ sâu răng: Khuôn khổ định lượng cho động học pH khoang miệng https://news.medxy.ai/advancing-cariogenic-risk-assessment-a-quantitative-framework-for-oral-ph-dynamics/Medxy AIen2026-11-11T06:14:25-08:00Advancing Cariogenic Risk Assessment: A Quantitative Framework for Oral pH Dynamics https://news.medxy.ai/zh/plozasiran-sirna-therapy/Medxy AIzh2026-11-11T06:13:37-08:00Plozasiran：一种可显著降低严重高甘油三酯血症及胰腺炎风险的新型 siRNA 疗法 https://news.medxy.ai/ja/plozasiran-pancreatitis-risk/Medxy AIja2026-11-11T06:13:19-08:00Plozasiran：重症高トリグリセリド血症と膵炎リスクを抑える新規siRNA治療 https://news.medxy.ai/vi/plozasiran-triglyceride-therapy/Medxy AIvi2026-11-11T06:12:57-08:00Plozasiran: Liệu pháp siRNA mới giúp hạ triglycerid mạnh và giảm nguy cơ viêm tụy https://news.medxy.ai/plozasiran-a-novel-sirna-therapy-reducing-severe-hypertriglyceridemia-and-pancreatitis-risk/Medxy AIen2026-11-11T06:12:41-08:00Plozasiran: A Novel siRNA Therapy Reducing Severe Hypertriglyceridemia and Pancreatitis Risk